Literature DB >> 29167895

Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer.

Ester Orlandi1, Lisa Licitra2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29167895     DOI： 10.1001/jamaoto.2017.2308

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN： 2168-6181            Impact factor:   6.223


× No keyword cloud information.
  3 in total

Review 1.  Big Data in Head and Neck Cancer.

Authors:  Carlo Resteghini; Annalisa Trama; Elio Borgonovi; Hykel Hosni; Giovanni Corrao; Ester Orlandi; Giuseppina Calareso; Loris De Cecco; Cesare Piazza; Luca Mainardi; Lisa Licitra
Journal:  Curr Treat Options Oncol       Date:  2018-10-25

Review 2.  Oral cancer: changing the aim of the biopsy in the age of precision medicine. A review.

Authors:  Roberto Bruschini; Fausto Maffini; Fausto Chiesa; Daniela Lepanto; Rita De Berardinis; Francesco Chu; Marta Tagliabue; Gioacchino Giugliano; Mohssen Ansarin
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

3.  Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.

Authors:  Shunsuke Kondo; Hitoshi Hirakawa; Taro Ikegami; Takayuki Uehara; Shinya Agena; Jin Uezato; Hidetoshi Kinjyo; Noritomo Kise; Yukashi Yamashita; Katsunori Tanaka; Narumi Hasegawa; Asanori Kiyuna; Hiroyuki Maeda; Mikio Suzuki; Akira Gahana
Journal:  BMC Cancer       Date:  2021-01-22       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.